<DOC>
	<DOCNO>NCT02504606</DOCNO>
	<brief_summary>This clinical trial evaluate compare safety pharmacokinetics Besylsartan Amosartan , available commercially single oral dose healthy male subject .</brief_summary>
	<brief_title>Safety Pharmacokinetics Besylsartan Tablet Healthy Male Subject</brief_title>
	<detailed_description />
	<mesh_term>Losartan</mesh_term>
	<criteria>Body Mass Index ( BMI ) 18 30 Healthy determine responsible physician History clinically significant disease Any chronic disease Creatine clearance le 50ml/min Hypotension ( 100mmHg/60mmHg ) Treatment barbital type drug within 1 month Administration herbal medicine within 7 day</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>